<i>JAMA</i> analysis examines link between ADHD meds, psychosis

A new meta‐analysis is raising fresh concerns about the psychiatric risks associated with stimulant treatment for attention‐deficit/hyperactivity disorder (ADHD). Drawing on data from nearly 400,000 individuals across 16 studies, researchers found that the occurrence of psychosis and bipolar disorder (BD) in stimulant‐treated patients was “nonnegligible.”